Search Results - "HOOK, Lauren"
-
1
An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infection
Published in PLoS pathogens (01-07-2020)“…HSV-1 causes 50% of first-time genital herpes infections in resource-rich countries and affects 190 million people worldwide. A prophylactic herpes vaccine is…”
Get full text
Journal Article -
2
Cytomegalovirus miRNAs Target Secretory Pathway Genes to Facilitate Formation of the Virion Assembly Compartment and Reduce Cytokine Secretion
Published in Cell host & microbe (12-03-2014)“…Herpesviruses, including human cytomegalovirus (HCMV), encode multiple microRNAs (miRNA) whose targets are just being uncovered. Moreover, miRNA function…”
Get full text
Journal Article -
3
An HSV-2 Trivalent Vaccine Is Immunogenic in Rhesus Macaques and Highly Efficacious in Guinea Pigs
Published in PLoS pathogens (01-01-2017)“…A genital herpes vaccine is urgently needed to prevent pain and suffering, reduce the incidence of neonatal herpes, and decrease the risk of HIV acquisition…”
Get full text
Journal Article -
4
Vaccine-induced antibodies to herpes simplex virus glycoprotein D epitopes involved in virus entry and cell-to-cell spread correlate with protection against genital disease in guinea pigs
Published in PLoS pathogens (01-05-2018)“…Herpes simplex virus type 2 (HSV-2) glycoprotein D (gD2) subunit antigen is included in many preclinical candidate vaccines. The rationale for including gD2 is…”
Get full text
Journal Article -
5
A trivalent gC2/gD2/gE2 vaccine for herpes simplex virus generates antibody responses that block immune evasion domains on gC2 better than natural infection
Published in Vaccine (21-01-2019)“…Highlights•Our goal is to produce antibodies to immune evasion domains through immunization. •Antibodies produced by HSV infection bind gC2 yet do not block…”
Get full text
Journal Article -
6
Vaccines to prevent genital herpes
Published in Translational research : the journal of laboratory and clinical medicine (01-06-2020)“…Genital herpes increases the risk of acquiring and transmitting Human Immunodeficiency Virus (HIV), is a source of anxiety for many about transmitting…”
Get full text
Journal Article -
7
Human Cytomegalovirus MicroRNAs miR-US5-1 and miR-UL112-3p Block Proinflammatory Cytokine Production in Response to NF-κB-Activating Factors through Direct Downregulation of IKKα and IKKβ
Published in mBio (07-03-2017)“…Emerging evidence indicates that human cytomegalovirus (HCMV) manipulates host cell signaling pathways using both proteins and noncoding RNAs. Several studies…”
Get full text
Journal Article -
8
A Trivalent HSV-2 gC2, gD2, gE2 Nucleoside-Modified mRNA-LNP Vaccine Provides Outstanding Protection in Mice against Genital and Non-Genital HSV-1 Infection, Comparable to the Same Antigens Derived from HSV-1
Published in Viruses (30-06-2023)“…HSV-1 disease is a significant public health burden causing orofacial, genital, cornea, and brain infection. We previously reported that a trivalent HSV-2 gC2,…”
Get full text
Journal Article -
9
Trivalent nucleoside-modified mRNA vaccine yields durable memory B cell protection against genital herpes in preclinical models
Published in The Journal of clinical investigation (01-12-2021)“…Nucleoside-modified mRNA vaccines have gained global attention because of COVID-19. We evaluated a similar vaccine approach for preventing a chronic, latent…”
Get full text
Journal Article -
10
Guinea Pig and Mouse Models for Genital Herpes Infection
Published in Current protocols (01-12-2021)“…This article describes procedures for two preclinical animal models for genital herpes infection. The guinea pig model shares many features of genital herpes…”
Get more information
Journal Article -
11
Herpes simplex virus type 2 trivalent protein vaccine containing glycoproteins C, D and E protects guinea pigs against HSV-1 genital infection
Published in Human vaccines & immunotherapeutics (01-09-2020)“…A vaccine to prevent genital herpes is an unmet public health need. We previously reported that a trivalent vaccine containing herpes simplex virus type 2…”
Get full text
Journal Article -
12
Antibody responses to crucial functional epitopes as a novel approach to assess immunogenicity of vaccine adjuvants
Published in Vaccine (27-06-2019)“…We are interested in developing a vaccine that prevents genital herpes. Adjuvants have a major impact on vaccine immunogenicity. We compared two adjuvants, an…”
Get full text
Journal Article -
13
Techniques for Characterizing Cytomegalovirus-Encoded miRNAs
Published in Methods in molecular biology (Clifton, N.J.) (2021)“…microRNAs (miRNAs) are small noncoding RNAs that regulate gene expression at the posttranscriptional level by binding to sites within the 3' untranslated…”
Get more information
Journal Article -
14
Novel Adjuvant S-540956 Targets Lymph Nodes and Reduces Genital Recurrences and Vaginal Shedding of HSV-2 DNA When Administered with HSV-2 Glycoprotein D as a Therapeutic Vaccine in Guinea Pigs
Published in Viruses (10-05-2023)“…Herpes simplex virus type 2 (HSV-2) is a leading cause of genital ulcer disease and a major risk factor for acquisition and transmission of HIV. Frequent…”
Get full text
Journal Article -
15
Antibodies to Crucial Epitopes on HSV-2 Glycoprotein D as a Guide to Dosing an mRNA Genital Herpes Vaccine
Published in Viruses (05-03-2022)“…The toxicity of mRNA-lipid nanoparticle (LNP) vaccines depends on the total mRNA-LNP dose. We established that the maximum tolerated dose of our trivalent…”
Get full text
Journal Article -
16
A trivalent subunit antigen glycoprotein vaccine as immunotherapy for genital herpes in the guinea pig genital infection model
Published in Human vaccines & immunotherapeutics (02-12-2017)“…An estimated 417 million people worldwide ages 15 to 49 are infected with herpes simplex virus type 2 (HSV-2), the most common cause of genital ulcer disease…”
Get full text
Journal Article -
17
Human Cytomegalovirus US7 Is Regulated Synergistically by Two Virally Encoded MicroRNAs and by Two Distinct Mechanisms
Published in Journal of Virology (01-11-2011)“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
18
Techniques for characterizing cytomegalovirus-encoded miRNAs
Published in Methods in molecular biology (Clifton, N.J.) (01-01-2014)“…microRNAs (miRNAs) are small noncoding RNAs that regulate gene expression at the posttranscriptional level, by binding to sites within the 3' untranslated…”
Get more information
Journal Article -
19
Blocking Antibody Access to Neutralizing Domains on Glycoproteins Involved in Entry as a Novel Mechanism of Immune Evasion by Herpes Simplex Virus Type 1 Glycoproteins C and E
Published in Journal of Virology (01-07-2008)“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
20
Herpes Simplex Virus Type 1 and 2 Glycoprotein C Prevents Complement-Mediated Neutralization Induced by Natural Immunoglobulin M Antibody
Published in Journal of Virology (01-04-2006)“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article